Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma (Q28216191)

2

0 references

Kazuhiro Nouso

3

0 references

Harushige Nakatsukasa

4

0 references

Toru Onishi

5

0 references

Tatsuya Fujikawa

6

0 references

Mayumi Taniyama

7

0 references

Shinichiro Nakamura

8

0 references

Masayuki Uemura

9

0 references

Yoshitaka Takuma

10

0 references

Eiichiro Yumoto

11

0 references

Toshihiro Higashi

12

0 references

Takao Tsuji

Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors

13

0 references

language of work or name

English

0 references

publication date

25 February 2002

0 references

published in

Cancer Letters

0 references

volume

176

0 references

page(s)

149-58

0 references

issue

2

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Genetic alterations during colorectal-tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Induction of the growth inhibitor IGF-binding protein 3 by p53

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Creation of human tumour cells with defined genetic elements

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Cancer epigenetics comes of age

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Abnormal lysosomal sorting with an enhanced secretion of cathepsin D precursor molecules bearing monoester phosphate groups

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021

Alteration in pancreatic immunoreactivity of insulin-like growth factor (IGF)-binding protein (IGFBP)-6 and in intracellular degradation of IGFBP-3 in fibroblasts of IGF-II receptor/IGF-II-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900736-4

7 January 2021